# Peniexpansones A–F: polyketides from Penicillium expansum DWS880 capable of enhancing the activity of fluconazole against Candida albicans

**Authors:** Wen-Yu Lu, Qing-Hui Xiao, Ai-Lin Liang, Peng-Ju Xu, Jing Li, Wen-Xuan Wang

PMC · DOI: 10.1007/s13659-026-00592-5 · Natural Products and Bioprospecting · 2026-03-03

## TL;DR

Scientists discovered new compounds from a soil fungus that can boost the effectiveness of a common antifungal drug against Candida albicans.

## Contribution

The discovery of peniexpansones A–F and their ability to enhance fluconazole's activity against drug-resistant Candida albicans.

## Key findings

- Peniexpansones A and B significantly improve fluconazole's antifungal activity against resistant Candida albicans.
- Peniexpansone C shows weak cytotoxicity and moderate antimicrobial activity against S. aureus and C. albicans.
- New polyketide structures were identified and characterized using advanced spectroscopic and computational methods.

## Abstract

Six new polyketides, peniexpansones A–F (1–4, 6, 7), along with an additional novel compound, (2E,4E,6E)-8-methyldeca-2,4,6-trienoic acid (5), and a known naphthopyrone, were isolated from the ethyl acetate extract of rice fermented with the soil fungus Penicillium expansum DWS880. Structurally, peniexpansones A–D feature a highly oxygenated tetrahydronaphthalene moiety linked to an acyl chain. The structures of the new compounds were elucidated by extensive spectroscopic analysis (1D/2D NMR and HRESIMS) and further supported by quantum chemical calculations. Peniexpansone C showed weak cytotoxicity against HCT116 cells (IC50 22.81 ± 0.42 μM) and moderate antimicrobial activity against pathogens including Staphylococcus aureus and Candida albicans. Moreover, peniexpansones A and B, can significantly improve the anti-fungal activity of fluconazole against resistant Candida albicans. Our results provided new structures for the future development of efficiency enhancement agents for anti-fungal drugs.

The online version contains supplementary material available at 10.1007/s13659-026-00592-5.

## Linked entities

- **Chemicals:** fluconazole (PubChem CID 3365)
- **Species:** Candida albicans (taxon 5476), Staphylococcus aureus (taxon 1280)

## Full-text entities

- **Diseases:** fungal (MESH:D009181), liver cancer (MESH:D006528), gastric (MESH:D013272), breast cancer (MESH:D001943), Cytotoxicity (MESH:D064420), colorectal cancer (MESH:D015179), cancer (MESH:D009369)
- **Chemicals:** C-8 (MESH:C037690), H (MESH:D006859), C-1 (MESH:C400149), H2SO4 (MESH:C033158), griseofulvin (MESH:D006118), 8S (MESH:C039415), fluconazole (MESH:D015725), C-2 (MESH:C023714), CO2 (MESH:D002245), chloroform (MESH:D002725), lipid (MESH:D008055), oil (MESH:D009821), H-7 (MESH:D019307), ethyl acetate (MESH:C007650), H-6 (MESH:C003027), 2H (MESH:D003903), 1,2,3-trisubstituted benzene (-), terbinafine (MESH:D000077291), 'S (MESH:D013455), C25H30O8 (MESH:C075123), H-9 (MESH:C044388), silica (MESH:D012822), Sephadex LH-20 (MESH:C025614), doxorubicin (MESH:D004317), penicillin (MESH:D010406), Na (MESH:D012964), KBr (MESH:C039004), alkaloids (MESH:D000470), methylene (MESH:C030011), ethanol (MESH:D000431), polyketide (MESH:D061065), JBIR-12 (MESH:C544288), erythromycin (MESH:D004917), 13C (MESH:C000615229), aldehyde (MESH:D000447), CCK-8 (MESH:D012844), lovastatin (MESH:D008148), water (MESH:D014867), peptides (MESH:D010455), C-6 (MESH:C117224), terpenes (MESH:D013729), petroleum ether (MESH:C004544), CO (MESH:D002248), cyclohexanone (MESH:C036468), H   C (MESH:D006854), C-4 (MESH:C058899), ester (MESH:D004952), ketone (MESH:D007659), streptomycin (MESH:D013307), C (MESH:D002244), tetralone (MESH:D044024), H-3 (MESH:C012616), silica gel (MESH:D058428), fumagillin (MESH:C026211), 3H (MESH:D014316), methanol (MESH:D000432), tetrahydronaphthalene (MESH:D013764), oxygen (MESH:D010100)
- **Species:** Acinetobacter baumannii (species) [taxon 470], Oryza sativa (Asian cultivated rice, species) [taxon 4530], Staphylococcus aureus (species) [taxon 1280], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Escherichia coli DH5[alpha] (strain) [taxon 668369], Homo sapiens (human, species) [taxon 9606], Fungi (kingdom) [taxon 4751], Penicillium expansum (species) [taxon 27334], Mus musculus (house mouse, species) [taxon 10090], Pseudomonas aeruginosa (species) [taxon 287], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Acinetobacter baumannii ATCC 19606 = CIP 70.34 = JCM 6841 (strain) [taxon 575584], Candida albicans (species) [taxon 5476], Bacillus subtilis (species) [taxon 1423]
- **Cell lines:** MHCC97H — Homo sapiens (Human), Adult hepatocellular carcinoma, Cancer cell line (CVCL_4972), 4T1 — Mus musculus (Mouse), Malignant neoplasms of the mouse mammary gland, Cancer cell line (CVCL_0125), JBIR-12 — Mus musculus (Mouse), Hybridoma (CVCL_J992), GES-1 — Homo sapiens (Human), Transformed cell line (CVCL_EQ22), HCT116 — Homo sapiens (Human), Colon carcinoma, Cancer cell line (CVCL_0291)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12953831/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12953831/full.md

---
Source: https://tomesphere.com/paper/PMC12953831